Tin tức & Cập nhật
Xem bài viết Niệu khoa
Xem
Chỉ hiển thị Multimedia

SBRT shows slightly lower late GI and GU toxicities than conventional RT in prostate cancer
24 Sep 2026
bởiKanas Chan
Stereotactic body radiotherapy (SBRT) provides comparable 5-year biochemical progression-free survival (PFS) and is associated with slightly lower rates of gastrointestinal (GI) and genitourinary (GU) toxicities compared with conventional radiotherapy (RT) in Chinese patients with low- to intermediate-risk prostate cancer, according to a real-world study in Hong Kong.
24 Sep 2026







